510(k) K133004
K133004 is an FDA 510(k) premarket notification submitted by Merck Millipore , Ltd. for the device "VENTED MILLEX -GV, CATHIVEX -GV". The FDA issued a decision of Substantially Equivalent on March 27, 2014. The device falls under product code BSN (Filter, Conduction, Anesthetic), a Class II device regulated under 21 CFR 868.5130. Merck Millipore , Ltd. has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 27, 2014
- Date Received
- September 25, 2013
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Filter, Conduction, Anesthetic
- Device Class
- Class II
- Regulation Number
- 868.5130
- Review Panel
- AN
- Submission Type